Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer
Work
Year: 2000
Type: article
Source: Oncology
Institutions Kitasato University Hospital, Showa University Hospital, Kyushu University, Yokufukai Hospital
Cites: 32
Cited by: 438
Related to: 10
FWCI: 10.83
Citation percentile (by year/subfield): 99.99
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed